本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Soleno Therapeutics

52.57
0.0000
盤後52.570.00000.00%18:58 EDT
成交量:415.46萬
成交額:2.19億
市值:27.14億
市盈率:134.79
高:52.68
開:52.57
低:52.53
收:52.57
52周最高:90.32
52周最低:29.43
股本:5,162.44萬
流通股本:4,487.09萬
量比:0.92
換手率:9.26%
股息:- -
股息率:- -
每股收益(TTM):0.3900
每股收益(LYR):0.3900
淨資產收益率:6.01%
總資產收益率:2.09%
市淨率:6.03
市盈率(LYR):134.79

資料載入中...

2025/01/24

重要事件披露

Form 8-K - Current report
2024/12/17

重要事件披露

Form 8-K - Current report
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/19

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/21

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/10

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/05

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]